SUBSCRIBE
SUBSCRIBE
News   Business

VasoGenix Pharmaceuticals, Inc. Elects Former AVAX Technologies, Inc. CEO Richard P. Rainey to Its Board of Directors

February 3, 2009 | 
1 min read
LENEXA, Kan.--(BUSINESS WIRE)--VasoGenix Pharmaceuticals announced today that Richard P. Rainey, CPA, former CEO of Avax Technologies, a publicly traded biotechnology company, has been elected to its board of directors.
People
MORE ON THIS TOPIC
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
ADC Therapeutics
ADC Therapeutics lays off 17% of global workforce
June 24, 2026
 · 
63 min read
 · 
BioSpace Editorial Staff
Mold spray. Mold control specialist. Hand in glove sprays the product antifungal. Dangerous fungus to kill. Man cleans bathroom cleaning products. Vector illustration flat design.
Manufacturing
Jubilant draws FDA rebuke for delayed mold investigation and quality unit lapses
June 24, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Concept art for large layoffs showing a line of blocks a cliff
Layoffs
ADC Therapeutics lays off staff after 27 patient deaths mar Zynlonta readout
June 24, 2026
 · 
2 min read
 · 
Gabrielle Masson
Isometric arrow overcoming above wall on turquoise blue background. Challenge, success, development and solution concept. Flat design. Vector illustration, no transparency, no gradients
Duchenne muscular dystrophy
REGENXBIO bets on FDA flexibility with filing plans for Duchenne gene therapy
June 24, 2026
 · 
2 min read
 · 
Gabrielle Masson